RNA Interference as a Therapeutic Approach for Managing Hypertension. [PDF]
Tan JW, Bhalla V.
europepmc +1 more source
Emerging trends in nanomedicine: The role of RNAi-based therapies and onpattro's clinical journey. [PDF]
Singh D +4 more
europepmc +1 more source
Current Management of Resistant Hypertension in Patients with Intracerebral Hemorrhage. [PDF]
Nguyen M +4 more
europepmc +1 more source
The Increasing Problem of Resistant Hypertension: We'll Manage till Help Comes! [PDF]
Natale F +8 more
europepmc +1 more source
Mechanisms and treatment of obesity-related hypertension-Part 2: Treatments. [PDF]
Parvanova A +3 more
europepmc +1 more source
Resistant Hypertension: Integration of Novel Agents and Interventional Approaches in Clinical Practice. [PDF]
Arriola-Montenegro J +12 more
europepmc +1 more source
MicroRNAs in Pediatric Primary Hypertension: Promising Biomarkers or Context-Dependent Regulators?-A Narrative Review. [PDF]
Szyszka M, Skrzypczyk P.
europepmc +1 more source
Safety profile of small interfering RNA therapeutics: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Ahn C +5 more
europepmc +1 more source
Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy? [PDF]
Kylies D, Dreher L, Wenzel UO.
europepmc +1 more source
Regulatory Approval vs Guideline Endorsement of Novel BP-Lowering Treatments. [PDF]
Revoori R, McEvoy JW, McCarthy CP.
europepmc +1 more source

